
How Much Weight Does Real-World Evidence Actually Carry at FDA?
Dr. Dereck Mush, MD, MBAInvestor
An investment and clinical forum highlighting the collaborative potential of academic medicine, industry partnerships, and emerging technology breakthroughs.
The forum is established by Mass General Brigham to bridge academic research, clinical care, and investment capital. It focuses on specific clinical themes each year, ranging from oncology to immunology and artificial intelligence. The event features panels with leading clinicians, biopharma executives, and early stage investors discussing translational medicine. For healthtech operators, it highlights the clinical priorities of one of the largest healthcare systems in the United States.
Global healthcare executives, venture capitalists, clinical researchers, and biotechnology entrepreneurs attend this event.
Mass General Brigham established the forum to accelerate the commercialization of academic discoveries. It has grown into a major hub for licensing executives, venture capital firms, and clinical researchers. Each year highlights the intersection of cutting-edge biology and technological applications.
Running this event, or spotted something out of date?

Dr. Dereck Mush, MD, MBA
Dr. Dereck Mush, MD, MBA
Dr. Dereck Mush, MD, MBA
Dr. Dereck Mush, MD, MBAKeep exploring